(cp) Chlorazepate
(cr) Diazepam
(em) Flurazepam
(hm) Oxazepam
CSB 2.09(2) (2) Addition of the thiophene analog of phencyclidine to schedule I. Paragraph (u) of sub. (4), s. 161.14, Stats., schedule I is hereby created to read:
(u) Thiophene analog of phencyclidine
CSB 2.09(3) (3) Addition of mecloqualone to schedule I. Subsection (5) and par. (a) of s. 161.14, Stats., schedule I are hereby created to read:
(5) Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
(a) Mecloqualone
CSB 2.09(4) (4) Addition of difenoxin to schedule I. Paragraph (hg) of sub. (2), s. 161.14, Stats., schedule I is hereby created to read:
(hg) Difenoxin
CSB 2.09(5) (5) Addition of 2,5 dimethoxyamphetamine, 4-romo-2,5 dimethoxyamphetamine and 4-methoxyamphetamine to schedule I. Paragraphs (v), (w) and (x) of sub. (4), s. 161.14, Stats., schedule I are hereby created to read:
(v) 2,5-dimethoxyamphetamine
(w) 4-bromo-2,5-dimethoxyamphetamine
(x) 4-methoxyamphetamine
CSB 2.09 Note Note: See Chapter 206, Laws of 1981 sections 13 and 15.
CSB 2.09 History History: Cr. Register, April, 1976, No. 244, eff. 5-1-76.
CSB 2.10 CSB 2.10 Addition of propiram to schedule I. Paragraph (wn) of sub. (2), s. 161.14, Stats., schedule I is hereby created to read:
(wn) Propiram
CSB 2.10 History History: Cr. Register, August, 1976, No. 248, eff. 9-1-76.
CSB 2.11 CSB 2.11 Renumbering and addition to schedule IV of diethylpropion and phentermine. Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
(b) Fenfluramine
Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read:
(a) Diethylpropion
Paragraph (b) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
(c) Pemoline
Paragraph (d) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read:
(d) Phentermine
CSB 2.11 History History: Cr. Register, August, 1976, No. 248, eff. 9-1-76.
CSB 2.13 CSB 2.13 Addition of dextropropoxyphene to schedule IV. Subsection (4), s. 161.20, Stats., schedule IV is hereby created to read:
(4) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:
(a) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane)
CSB 2.13 Note Note: See Chapter 206, Laws of 1981 section 51.
CSB 2.13 History History: Cr. Register, November, 1977, No. 263, eff. 12-1-77.
CSB 2.14 CSB 2.14 Addition of prazepam to schedule IV. Paragraph (km), sub. (2), s. 161.20, Stats., schedule IV is hereby created to read:
(km) Prazepam
CSB 2.14 History History: Cr. Register, November, 1977, No. 263, eff. 12-1-77.
CSB 2.15 CSB 2.15 Addition of parahexyl to schedule I; removal of loperamide from schedule V; addition of triazolam to schedule IV.
CSB 2.15(1)(1)Paragraph (mn) of sub. (4), s. 161.14, Stats., is created to read:
(mn) Parahexyl
CSB 2.15(2) (2)Paragraph (a) of sub. (3), s. 161.22, Stats., is repealed.
CSB 2.15(3) (3)Paragraph (nm) of sub. (2), s. 161.20, Stats., is created to read:
(nm) Triazolam
CSB 2.15 History History: Cr. Register, October, 1984, No. 346, eff. 11-1-84.
CSB 2.16 CSB 2.16 Transfer of sufentanil from schedule I to schedule II.
CSB 2.16(1)(1)Section 161.14 (2) (xg), Stats., is repealed.
CSB 2.16(2) (2)Section 161.16 (3) (y), Stats., is created to read:
(y) Sufentanil
CSB 2.16 History History: Cr. Register, October, 1984, No. 346, eff. 11-1-84.
CSB 2.17 CSB 2.17 Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II.
CSB 2.17(2)(2)Paragraph (b) of s. 161.14 (5), Stats., is adopted to read:
(b) Methaqualone
CSB 2.17(3) (3)Subsection (7) (am) of s. 161.16, Stats., is repealed.
CSB 2.17(4) (4)Subsection (10) (a) of s. 161.16, Stats., is created to read:
(10) Hallucinogenic substances. (a) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. food and drug administration approved drug product. (Other names for dronabinol are (6a R - trans) - 6a, 7, 8, 10a - tetrahydro - 6, 6, 9 - trimethyl - 3 -pentyl-6H-dibenzo (b, d) pyran - 1 - ol, or (-) - delta - 9 - (trans) - tetrahydrocannabinol.)
CSB 2.17 History History: Cr. Register, August, 1986, No. 368, eff. 9-1-86; CR 03-056: r. (1) Register January 2004 No. 577, eff. 2-1-04.
CSB 2.18 CSB 2.18 Addition of 3,4-methylenedioxymethamphetamine to schedule I. Paragraph (am) of s. 161.14 (4), Stats., is created to read:
(am) 3, 4-methylenedioxymethamphetamine, commonly known as“MDMA";
CSB 2.18 History History: Cr. Register, September, 1987, No. 381, eff. 10-1-87.
CSB 2.19 CSB 2.19 Additions, deletions and transfers to statutory schedules.
CSB 2.19(1)(1)Paragraph (b) of s. 161.20 (4), Stats., is created to read:
(b) Not more than 25 milligrams per dosage unit of pentazocine with one or more active, non-narcotic ingredients in recognized therapeutic amounts.
CSB 2.19(2) (2)Paragraph (b) of s. 161.18 (4), Stats., is repealed.
CSB 2.19(3) (3)Paragraph (km) of s. 161.20 (2), Stats., is renumbered to read:
(mg) Prazepam;
CSB 2.19(4) (4)Paragraph (hg) of s. 161.20 (2), Stats., is created to read:
(hg) Midazolam;
CSB 2.19(5) (5)Paragraph (mm) of s. 161.20 (2), Stats., is created to read:
(mm) Quazepam;
CSB 2.19(6) (6)Paragraph (km) of s. 161.18 (3), Stats., is created to read:
(km) Tiletamine and Zolazepam or any salt thereof;
CSB 2.19(7) (7)Paragraph (a) of s. 161.16 (3), Stats., is renumbered to read:
(am) Alphaprodine;
CSB 2.19(8) (8)Paragraph (a) of s. 161.16 (3), Stats., is created to read:
(a) Alfentanil;
CSB 2.19(9) (9)Paragraph (rg) of s. 161.14 (2), Stats., is created to read:
(rg) MPPP 1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.19(10) (10)Paragraph (vg) of s. 161.14 (2), Stats., is created to read:
(vg) (PEPAP) 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;
CSB 2.19(11) (11)Paragraph (b) of s. 161.16 (10), Stats., is created to read:
(b) Nabilone (another name for nabilone: (+)-trans-3- (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1- hydroxy-6, 6-dimethyl-9H-dibenzo [b,d] pyran-9-one).
CSB 2.19(12) (12)Subsection (2) of s. 161.14, Stats., is amended to read:
(2) Opiates. Unless specifically excepted under federal regulations or unless listed in another schedule, any of the following opiates, or their isomers, esters, ethers, salts, salts of isomers, esters of ethers, if isomers, esters, ethers, salts or salts of isomers exist within the specified chemical designation (for purposes of par. (tg) only, the term isomer includes the optical and geometric isomers):
CSB 2.19(13) (13)Paragraph (a) of s. 161.14 (2), Stats., is renumbered to read:
(ag) Acetylmethadol;
CSB 2.19(14) (14)Paragraph (a) of s. 161.14 (2), Stats., is created to read:
(a) Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.19(15) (15)Paragraph (cg) of s. 161.14 (2), Stats., is created to read:
(cg) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
Loading...
Loading...
Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published.